“Trastuzumab-Conjugated Nanoparticles: Design And Synthesis Of Trastuzumab-Conjugated Nanoparticles For Targeted Delivery Of Chemotherapeutic Agents To Her2-Positive Breast Cancer Cells”. Vascular and Endovascular Review, vol. 8, no. 12s, Nov. 2025, pp. 310-5, https://verjournal.com/index.php/ver/article/view/957.